click below
click below
Normal Size Small Size show me how
CNS 2 Spears
Depression and Antidepressants
| Question | Answer |
|---|---|
| What are the types of depression? | MDD--> Persistent Depressive Disorder Anxious Depression Atypical Depression Melancholic Depression Mood reactivity + Hypersomnia/Increased appetite & weight -Psychotic depression -Peripartum/postpartum depression -Tx resistant depression |
| Peripartum/Postpartum depression (PPD) has 2 medications available, which are? *not the baby blues (difference due to persistence of depression symptoms) | 1) Zuranolone oral treatment for PPD (approved 2023) GABA-A modulator, mimic allopregnanolone 2) Brexanolone I.V. treatment for PPD (approved 2019) MOA: positive GABA-A receptor modulator Boxed warning excessive sedation, sudden loss of consciousness |
| MDD (Major depressive disorder) definition? | Persistent, low mood with loss of enjoyment and pleasure |
| Causes of depression can be? | Genetic, environmental, psychological, Biochemical (NT, Inflammatory markers) |
| Differences b/w monoamines--> Which of the monoamines are classified as Catecholamines? | DA and NE |
| Differences b/w monoamines--> Which of the monoamines is not considered a catecholamine? | Serotonin |
| What is the precursor of dopamine? | Tyrosine |
| Precursor of NE? | Tyrosine |
| Precursor to Serotonin? | Tryptophan |
| The _____ system is known as the emotional brain | Limbic -brain stem, amygdala, hippocampus, hypothalamus |
| What area of the brain is known as the cognitive brain? | prefrontal cortex |
| depression is caused by a ______ in monamines (5-HT, DA, NE) | decrease *depression + tx = increase in monoamines |
| What are the names of the 2 hypothesis? | 1. Monoamine hypothesis 2. Neurotropic hypothesis |
| The monoamine hypothesis is? | Deficency in the amount or function of 5-HT, NE, or DA |
| Monoamine hypothesis: *NTs are differently _______ in depression subtypes | imbalanced *not necessarily a deficency that the body is not making it at all, but in certain brain regions and in certain symptoms of depression, some are more active or less active than others. This could be incorporated (not only in decreases in the production of the NT byt also the effectiveness at its receptor |
| I.e. Atypical depression: may not benefit from a medication that prefers to increase 5-HT, might need a medication that has a bigger effect on ________ Noradrenegic and DA | increasing |
| Melancholic depression has more Noradrenergic and 5-HT and less ______ | DA |
| T/F the monoamine hypothesis and the neurotropic hypothesis happen at different times | False (they occur at the same time) |
| What is the Neurotropic (Stress) hypothesis? | there is a decrease in brain-derived neurotrophic factor (BDNF) -BDNF promotes synaptic remodeling (i.e an incerase in dendrict sprouts--> and when there is more dendritic sproites, there are more synapes so the NT can be more effective but with this hyptheis there is less BDNF |
| What is the reasons antidepressants take a long time to work? | in the body, the amount of NT's increase rapidly at the synapse so the reason these medications take a long time to work isnt b/c of how long it takes to generate more NT's its bc it takes a long time (3-8 wks to increase BDNF so that there is more expression of dendritic sprouts |
| In a treated state as shown in the Neurotrophic hypothesis--> BDNF is elevated to get more dendritic sprouts. More sprouts menas | more synapses, menaing more of that neuronal connections that can be occuring--> more effectveness of tht NT that are released from those areas |
| what drug classes are transport blockers? | SSRIs; SNRIs; TCAs; NDRI |
| What class of drug is a degradation blocker? | MAOIs |
| ________ antidepressants are classified as "other" | atypical |
| general SE of blocking adrenergic a-1 receptors? | orthostatic hypotension |
| general SE of blocking Histamine (H1) receptors? | Drowsiness and weight gain |
| general SE of blocking cholinergic, mACh, M1 receptors? | ANTI-SLUDGE (dry mouth, constipation, confusion) |
| general SE of receptor activation of Serotonin, 5H2 receptors? | Sexual dysfunction -Serotonin is centrally and peripherally acting |
| general SE of activating 5HT2 receptors? | insomnia/agitation |
| general SE of activating 5HT3 receptors? | GI/Nausea |
| general SE of activating NE receptors? | hypertension/increased HR |
| When using meds that activate the receptor, do we want high or low doses? | LOW |
| ______ syndrome is true for ALL antidepressants | Discontinuation -Unmonitored tapering/end abrupt changes in brain Dizziness, nausea, anxiety, agitation, lethargy Shorter half-life = More of a problem (e.g., paroxetine)** |
| Which antidepressant has a shorter 1/2 life so that discontinuation syndrome is more of a problem? | Paroxetine |
| What is serotonin syndrome toxicity? | Mild to severe neuromuscular & autonomic hyperactivity |
| Suicide risk (ideation attemps are _____ for ALL antidepressants | TRUE *greater risk in younger ages *immediate notifications |
| Which medications are classified as SSRIs? | Citalopram (Celexa ®) & Escitalopram (Lexapro®) Fluoxetine (Prozac®) Fluvoxamine (Luvox®) (*also for OCD) Paroxetine (Paxil®) Sertraline (Zoloft®) |
| _____ has a higher risk of sexual dysfunctio, weight gain, and discontinuation syndrome | Paroxetine |
| Which SSRI has the longest 1/2 life? | Fluoxetine |
| Which SSRI has the shortest 1/2 life? | Paroxetine |
| This SSRI has activitity not only on SERT but can also has antagonist activation at NET, M1, and a1? | Paroxetine |
| Fluoxetine has antagonist activity not only at SERT but also on? | 5-HT2 |
| Vortioxetine (Trintellix) is an SSRI with antagonism at SERT and also on ____ | NET Agonist: 5-HT1A Partial agonist: 5-HT1B Antagonist: 5-HT1D, 5-HT3, 5-HT7 |
| Which drugs are SNRIs? | Venlafaxine (Effexor®) & Desvenlafaxine (Pristiq®) Duloxetine (Cymbalta®) Milnacipran (Savella®) & Levomilnacipran (Fetzima®) |
| SE of SNRIs include? | Sexual dysfunction Nausea Headache, dizziness Sedation Insomnia Increased blood pressure, hr **Discontinuation & Serotonin Syndromes** |
| SNRIS such as _______ have less antagonist activity at the off-target receptors (5-HT2, H1, M1, a1) | Venlafaxine/Desvenlafaxine Duloxetine Milnacipran/Levomilnacipran |
| Duloxetine has ____ affinity for atagonist acitivty at SERT and NET | equal (+++) |
| Venlafaxine/Desvenlafaxine have ++ at the ______ and + at _____ | SERT; NET |
| Milnacipran/Levomilnacipran have + at the _____ and +++ at ___ | SERT; NET *favors NET |
| TCA medications include? | Amoxapine Amitriptyline (Elavil®) Nortriptyline (Pamelor®) Doxepin (Sinequan®) Imipramine (Tofranil®) Clomipramine (Anafranil®) Desipramine (Norpramin®) |
| TCA MOA? | SERT & NET Blockers + Non-specific receptor blockers |
| TCA class Notes? (4) | -Narrow TI -Cardica Toxicity (Na+ channel blockers) -Seizures -Discontinuation syndrome |
| The following TCAs are classified as secondary amines: | Amoxapine; Nortriptyline (Pamelor); Desiprmaine (Norprmain) |
| The following TCAs are classified as tertiary amines: | amitriptyline; doxepin; imipramine; clomipramine |
| TCAs cause lots of ADRs (T/F) | True (ton of off-target receptor binding so more AE compared to traditional exclusive blockers) |
| What AE are caused by anti-histaminergic? | sedation, increased appetite |
| What AE are caused by Anti-muscarinic? | Anti-SLUD effects: dry mouth, urinary retention, constipation + confusion, arrythmias |
| What AE are caused by Adrenergic a1? | Orthostatic hypotension |
| TCA MOA is? | blocks 5-HT, NET, H1, and muscarinic receptors |
| NDRI (Norepinephrine and Dopamine Reuptake Inhibitor drug is? | Bupropion (Wellbutrin, Zyban) |
| MOA of Bupropion: | DAT(>>>) & NET Blocker Presynaptic NT release *favors DAT |
| AE of Bupropion includes? | -Insomnia - Seizures - Hypertension - Hallucinations/Psychosis |
| CI of Bupropion? | -Antiepileptic drugs -Eating disorders -MAOIs |
| Bupropion comes with low risk of? | Sexual dysfunction (due to bupropion not targeting serotonin), nausea (b/c its not hitting 5-HT3), weight gain (not hitting the H1 receptor) |
| Which medications are classified as MAOIs? | Phenelzine (Nardil®) Isocarboxazid (Marplan®) Selegiline (patch) – (Emsam®) Tranylcypromine (Parnate®) PIST |
| MOA for MAOIs? | inhibit MAO causing monoamines to not get broken down so there will be an increase in NTs available in the sybaptic space and in the cleft |
| where do MAOIs work? | centrally and peripherally |
| Lifespan of MAOIs? | 2-3 weeks |
| MAOIs are irreversible and ______ | non-selective |